Am I eligible for a clinical trial if I have Lung Cancer
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Clinical Trial Eligibility for Lung Cancer
Great question! Clinical trial eligibility depends on several factors specific to your situation, and the answer isn't one-size-fits-all. Let me explain how this works and what you should discuss with your care team.
How Clinical Trial Eligibility Works
According to NCCN Guidelines for Patients, clinical trials are an important part of lung cancer treatment options. Your eligibility typically depends on:
Your specific cancer characteristics:
- Stage of your lung cancer (early, locally advanced, or metastatic)
- Type of NSCLC (adenocarcinoma, squamous cell, large cell, etc.)
- Genetic mutations or biomarkers (like EGFR, ALK, KRAS, PD-L1)
- Whether you've had previous treatments
Your overall health:
- Performance status (how well you're functioning day-to-day)
- Other medical conditions you may have
- Organ function (liver, kidney, heart)
- Previous cancer treatments
The specific trial's requirements:
- What stage of cancer it's studying
- What treatment it's testing
- How many patients they need
- Geographic location and availability
Current Lung Cancer Trial Landscape
There are several active areas of clinical research for lung cancer:
- Early detection trials: For example, the CASCADE-LUNG trial (mentioned in current research) is studying blood-based tests to identify lung cancer earlier in high-risk patients
- Treatment trials: Testing new chemotherapy combinations, immunotherapy approaches, and targeted therapies
- Combination therapy trials: Studying how different treatments work together (like chemoradiation plus immunotherapy)
Questions to Ask Your Oncology Team
To determine YOUR eligibility, have this conversation with your care team:
-
"Are there clinical trials available for my specific type and stage of lung cancer?" (This helps identify what's actually open and relevant to you)
-
"What are the eligibility criteria for trials you're recommending, and do I meet them?" (Get specific about YOUR situation)
-
"What would be the potential benefits and risks of participating in a trial versus standard treatment?" (Understand the trade-offs)
-
"How would a trial affect my treatment schedule and monitoring?" (Practical considerations)
-
"Can you help me access trial information through ClinicalTrials.gov or other resources?" (Your doctor can help you search)
Where to Find Trials
- ClinicalTrials.gov - Search by cancer type, location, and stage
- Your cancer center's research department - They often have trials available
- National Cancer Institute (NCI) - Maintains comprehensive trial databases
- Advocacy organizations - Many lung cancer organizations maintain trial registries
Important Context
Not every patient is eligible for every trial, and that's okay. Your oncologist will help match you with trials that make sense for YOUR specific cancer and health situation. Being ineligible for one trial doesn't mean you won't qualify for others.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Non-Small Cell Lung Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Lung Cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →